Most people who experience chronic fatigue have been told at some point to “sleep more” or “reduce stress” — well-meaning advice that is as practically useful as telling someone with diabetes to “produce more insulin.” The physiological reality of HPA axis dysregulation is that chronic stress produces a specific pattern of cortisol disruption that is not remedied by sleep alone, and that requires a targeted approach to restore the normal rhythm of the stress response system.
The Normal HPA Axis Rhythm
The hypothalamic-pituitary-adrenal (HPA) axis operates on a circadian rhythm with a characteristic waveform: cortisol begins to rise at approximately 4-5am, peaks at the cortisol awakening response (30-45 minutes after waking), declines gradually through the morning and afternoon, reaches a nadir at approximately midnight, and then begins rising again toward the next morning peak. This rhythm is one of the most robust and consistent biological rhythms in human physiology, and it is measurable with a four-point salivary cortisol sampling protocol across the day.
The morning cortisol peak is not simply a passive response to waking — it requires an intact HPA axis, adequate adrenal function, and an appropriately phased suprachiasmatic nucleus (the master clock). Disruption at any of these three nodes flattens the rhythm. The most common disruption is an exaggerated morning peak combined with a failure of the normal decline — cortisol stays elevated in the afternoon and evening when it should be falling.
What Chronic Stress Does to the HPA Axis
Acute stress triggers a predictable HPA activation: CRH from the hypothalamus stimulates ACTH from the pituitary, which stimulates cortisol from the adrenal glands. After the stressor resolves, cortisol feeds back negatively to suppress further CRH and ACTH release, and the system returns to baseline. This is the normal stress response — adaptive, time-limited, and self-limiting.
Chronic stress, however, produces a different pattern. The sustained elevation of CRH (from ongoing psychological stress, metabolic stress, or inflammatory stress) leads to downregulation of CRH receptors in the pituitary, desensitisation of the adrenal glands to ACTH, and eventually to a flattened cortisol response — sometimes called “adrenal fatigue” though the more accurate clinical term is HPA axis dysregulation. The paradox is that people with this pattern often have LOW morning cortisol (because the adrenal response has been blunted) but STILL have elevated evening cortisol (because the hypothalamic CRH release is still chronically activated).
The Cortisol Awakening Response as a Diagnostic Marker
The cortisol awakening response (CAR) — the rise in cortisol in the first 30-45 minutes after waking — is the most sensitive marker of HPA axis function and the most reproducible diagnostic indicator of HPA axis dysregulation. In healthy individuals, cortisol rises by 40-60% from the waking baseline within 30 minutes. In people with HPA axis dysregulation from chronic stress, this rise is either blunted (less than 40% increase — hyporesponsive pattern) or exaggerated (more than 60% increase — hyperresponsive pattern), and the trajectory of decline through the rest of the day is abnormal.
The CAR can be measured at home with a salivary cortisol collection kit taken at waking, +30 minutes, and +60 minutes. The pattern of these three values, plotted against the normal reference range, reveals the specific dysregulation phenotype and guides the therapeutic approach.
Restoring HPA Axis Function
The most evidence-based interventions for HPA axis dysregulation target the hypothalamic CRH output directly. Ashwagandha (Withania somnifera) is one of the most studied botanicals for this application — multiple RCTs show it reduces subjective stress scores and normalises cortisol patterns in people with chronic stress. Phosphatidylserine (PS) at 600mg daily has been shown to blunt the cortisol response to acute physical stress and is particularly useful in athletes whose training stress produces HPA axis dysregulation.
Lifestyle interventions that activate the parasympathetic nervous system — slow nasal breathing, meditation, yoga, and time in nature — directly reduce hypothalamic CRH output and restore the normal diurnal cortisol pattern. These are not soft or optional interventions — they are the mechanistic equivalent of removing the chronic stressor that is driving the dysregulation. Magnesium, through its antagonism of the NMDA receptor and its support of GABAergic inhibition, also has a moderating effect on HPA axis activity and is a useful adjunct to the above interventions.
KSM-66 vs Other Extracts: Why the Form Matters
Not all ashwagandha extracts are created equal. The KSM-66 extract, standardised to greater than 5% withanolides and derived from roots only, has the largest and most rigorous trial database, demonstrating meaningful reductions in perceived stress scores within 8-12 weeks in multiple randomised controlled trials. Many commercial products use whole-root powders or low-potency leaf extracts containing minimal withanolides. Evidence-based supplementation requires a standardised extract at 300-600mg per day of KSM-66 or equivalent.
Mechanism: How Withanolides Calm the Nervous System
The active constituents bind GABA-A receptors, producing anxiolytic effects without sedation, inhibit cortisol synthesis in adrenal cortex cells, and reduce neuroinflammation via NF-kB and TNF-alpha suppression. Unlike pharmaceutical anxiolytics, standard doses do not impair cognitive performance or create physical dependence. The cortisol-lowering effect is particularly relevant for people whose stress manifests as metabolic dysfunction.
Leave a Reply